Cascade Pharmaceuticals, Inc
Clinical trials sponsored by Cascade Pharmaceuticals, Inc, explained in plain language.
-
New hope for liver disease patients who run out of options
Disease control Recruiting nowThis study is testing an investigational drug called CS0159 for adults with primary biliary cholangitis (PBC), a chronic liver disease, who do not respond well to or cannot tolerate the standard medication. About 135 participants will take either CS0159 or a placebo pill daily fo…
Phase: PHASE3 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Apr 03, 2026 21:11 UTC
-
New pill aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing an investigational pill called CS060380 to see if it can safely reduce liver fat and improve health in people with non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. About 120 adults will take either the study drug or a placebo (a d…
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC